Principal Financial Group’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History
Bought
Maintained
Sold
Principal Financial Group's RPTP Position: Q4 2016 in Review
Principal Financial Group sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 15,051 shares — an estimated $135K sold.
Principal Financial Group first reported a position in RPTP in Q3 2013 and held it in 11 quarters. The position peaked at $247K in Q3 2013. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.
- Principal Financial Group reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
- Principal Financial Group sold 15,051 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $135K.
- Principal Financial Group first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2013 and held it in 11 quarters.
- Principal Financial Group's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $247K in Q3 2013.
- 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.
Based on Principal Financial Group's 13F filing for Q4 2016, filed 13 Feb 2017.